Your browser doesn't support javascript.
loading
Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
Gommoll, Carl; Forero, Giovanna; Mathews, Maju; Nunez, Rene; Tang, Xiongwen; Durgam, Suresh; Sambunaris, Angelo.
Affiliation
  • Gommoll C; aForest Research Institute, an affiliate of Actavis Inc., Harborside Financial Center, Jersey City, New Jersey bAtlanta Institute of Medicine & Research, Atlanta, Georgia, USA.
Int Clin Psychopharmacol ; 30(6): 297-306, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26291335
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Anti-Anxiety Agents / Serotonin 5-HT1 Receptor Agonists / Vilazodone Hydrochloride Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Anti-Anxiety Agents / Serotonin 5-HT1 Receptor Agonists / Vilazodone Hydrochloride Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2015 Document type: Article Affiliation country: Country of publication: